Regulation

Regulation

Cannabis Regulators Work to Forge a Path on Interstate Commerce 

States along the west coast have already passed laws to allow for “controlled” interstate commerce – when federal law changes.

Regulation

What Else Is In HHS’ Cannabis Rescheduling Docs?

Many groups’ work, from CANNRA to the National Academies of Sciences, Engineering, and Medicine, informed a federal recommendation to reclassify cannabis.

Regulation

State Medical Cannabis Programs, Booming Research, Informed HHS Recommendation to Reclassify Cannabis

Newly released documents from the Dept. of Health and Human Services detail the agency’s recommendation to the DEA to put cannabis in Schedule III.

Regulation

National Academies’ Cannabis Committee Convenes Again

The second meeting of the Committee on the Public Health Consequences of Changes in the Cannabis Policy Landscape is underway this week. Here’s what happened on day one.

Regulation

How Many Cannabis Products Have Been Recalled in 2023? You Might Never Know. 

There’s no consistency among states about how to disclose recalled cannabis products.

Regulation

New CDC Report Explores Asthma Risks for Cannabis Workers

The CDC, NIOSH, and the Massachusetts Department of Public Health published reports and bulletins this week following their investigations into a cannabis worker’s death in 2022.

Regulation

FDA Looks Back On Fifty Years of Cannabis Research, Prepares for Growth Ahead

FDA researchers published an article this week titled “From Our Perspective: FDA’s 50 Years of Experience with Cannabis Research Helping to Support Tomorrow’s Cannabis Drug Development.”

Policy, Regulation

American Enterprise Institute Hosts Cannabis Conversation: “You Can Either Get on the Bus or You Can Get Hit By It.” 

The center-right think tank hosted a cannabis policy discussion in D.C. on Wednesday focused on the future of federal reforms.

Regulation

U.S. Census Bureau Releases First Cannabis Data Product 

The “experimental data product” focused on excise sales tax revenue is the Bureau’s most comprehensive cannabis data collection effort to date.

Regulation

Federal Cannabis Review Reaches Milestone as HHS Recommends Schedule III Reclassification

The scheduling review, prompted by Pres. Biden in October, could reshape the cannabis policy landscape in the U.S. Now, the DEA will decide.

Regulation

At FDLI Conference, State and Federal Regulators Convene Over Cannabis, CBD, Equity, and Animals

The two-day FDLI conference focused on thorny questions in cannabis regulation, and included the FDA and other regulators.

Regulation

As FDA Looks to Congress for CBD Regs, it Elaborates on Potential Paths Forward 

On Thursday, the FDA pushed its desire to work with Congress on cannabinoid product rules, including delta-8 THC.

Regulation

CBD’s Potential for Reproductive Harms Among “Big Reasons” Behind FDA’s Punt on Rules

The FDA is seeking a “harm reduction framework” as it works with Congress on a path for CBD, according to the agency’s Cannabis Product Committee lead.

Regulation

Amid Booming Cannabis Industry, State Insurance Regulators Call for “Safe Harbor” in New White Paper

A working group of the National Association of Insurance Commissioners plans to present the final paper at the Association’s Summer National Meeting in August.

Regulation

Top “Threat” to Legal Cannabis? Confusion Over Intoxicating Hemp Products, Says Head of CANNRA

Will the 2023 Farm Bill fix some of the confusion caused by the 2018 version that legalized hemp? State regulators and industry regulators hope Congress acts fast.

CBD, Regulation

FDA’s Cannabis Advisor: Approach to CBD Rules Shouldn’t Let “Perfect be the Enemy of the Good”

Norman Birenbaum spoke about the FDA’s cannabis-related efforts during a discussion on Thursday hosted by the Council for Federal Cannabis Regulation.